Park Yohan, Lee Ji Won, Yoon Se-Hee, Hwang Won Min, Yun Sung-Ro, Son Ji-Young, Chung Byung Ha, Min Jiwon
Division of Nephrology, Department of Internal Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon, Republic of Korea.
Division of Nephrology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Clin Kidney J. 2024 Apr 8;17(6):sfae102. doi: 10.1093/ckj/sfae102. eCollection 2024 Jun.
Intradialytic hypotension (IDH) is the primary complication of haemodialysis (HD); however, its diverse pathophysiology and inconsistent definitions complicate its prediction. Despite attempts using the heart rate variability (HRV) test for IDH prediction, studies on its usefulness for predicting IDH diagnosed per the nadir 90 criterion are lacking. We aimed to evaluate HRV test efficacy and reproducibility in predicting IDH based on the nadir 90 criterion.
Seventy patients undergoing HD participated in this multicentre prospective observational study. The HRV test was performed during non-HD periods and IDH was monitored during 12 HD sessions. IDH was diagnosed according to the nadir 90 criterion, defined as a decrease in systolic blood pressure of ≤90 mmHg during HD. After monitoring, the HRV test was repeated. An HRV-IDH index was developed using multivariate logistic regression analysis employing HRV test parameters. The predictive power of the HRV-IDH index was analysed using the area under the receiver operating characteristics curve (AUROC). Reproducibility was evaluated using correlation analysis of two HRV tests on the same patient.
There were 37 and 33 patients in the IDH and non-IDH groups, respectively. The HRV-IDH index predicted IDH occurrence with AUROCs of 0.776 and 0.803 for patients who had experienced at least one or repeated IDH episodes, respectively. Spearman's correlation coefficient for HRV-IDH indices was 0.859 for the first and second HRV tests.
The HRV test holds promise for predicting IDH, particularly for patients with recurring IDH diagnosed based on the nadir 90 criterion.
透析中低血压(IDH)是血液透析(HD)的主要并发症;然而,其多样的病理生理学和不一致的定义使其预测变得复杂。尽管尝试使用心率变异性(HRV)测试来预测IDH,但缺乏关于其对根据最低点90标准诊断的IDH预测效用的研究。我们旨在评估基于最低点90标准预测IDH时HRV测试的有效性和可重复性。
70例接受HD的患者参与了这项多中心前瞻性观察研究。在非HD期间进行HRV测试,并在12次HD治疗期间监测IDH。根据最低点90标准诊断IDH,该标准定义为HD期间收缩压下降≤90 mmHg。监测后,重复进行HRV测试。使用HRV测试参数通过多变量逻辑回归分析建立HRV-IDH指数。使用受试者工作特征曲线下面积(AUROC)分析HRV-IDH指数的预测能力。使用对同一患者的两次HRV测试的相关性分析评估可重复性。
IDH组和非IDH组分别有37例和33例患者。对于至少经历过一次或多次IDH发作的患者,HRV-IDH指数预测IDH发生的AUROC分别为0.776和0.803。第一次和第二次HRV测试的HRV-IDH指数的Spearman相关系数为0.859。
HRV测试在预测IDH方面具有前景,特别是对于根据最低点90标准诊断的复发性IDH患者。